
Waters (WAT) Stock Forecast & Price Target
Waters (WAT) Analyst Ratings
Bulls say
Waters is supported by a stronger fundamental profile as its core analytical instruments business reaccelerates, with 3Q organic revenue up 10%, instruments up 10%, chemistry up 12%, and services up 8%, while full-year constant-currency growth guidance was raised to 9.1%–9.7% from 7.0%–9.0%. Its positive outlook is reinforced by the early-2026 merger with Becton Dickinson’s life science and diagnostics business, which adds turnaround and synergy potential through pricing, localization, and cost savings, while expanding exposure to diagnostics and discovery-related tools. Management also has durable end-market tailwinds from pharma manufacturing, GLP-1 workflows, China recovery, and reshoring, alongside new growth vectors from AI, replacement cycles, and the MOBILion acquisition into a ~$2.2 billion proteomics market.
Bears say
Waters is facing a fundamentally weaker outlook because the BD acquisition adds structurally challenged Biosciences & Diagnostics businesses just as core analytical instruments growth faces tougher comps, raising the risk that organic sales momentum permanently slows. The transaction also increases operational complexity and absorbs management time, while roughly $4B of assumed debt on top of existing debt constrains capital allocation flexibility and leaves the balance sheet less able to respond to any disappointment. If integration hiccups, slower-than-expected end-market recovery, or underperformance in the acquired assets occur, multiple compression could follow from several directions at once, especially given the five-year bottom ~23x P/E reference.
This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.
Waters (WAT) Analyst Forecast & Price Prediction
Start investing in Waters (WAT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Waters (WAT) Forecast
Waters (WAT) Analyst Forecast & Price Prediction
Start investing in Waters (WAT)
Order type
Buy in
Order amount
Est. shares
0 shares